FNIH
at-a-Glance

  • Creating and managing a diverse portfolio or initiatives.
  • Developing diverse and uncommon collaborations.
Open post
OUR PARTNERSHIPS

Every day, the FNIH forges new models of collaboration where all partners can contribute and thrive. Our collective impact is much greater than what any single organization could achieve on its own.

fnih-graph

WHAT WE DO

The FNIH stands at the center of a wide portfolio of initiatives focused on a shared goal: advancing biomedical science to improve lives.

RESEARCH PARTNERSHIPS — We develop collaborations with top experts from government, industry, academia and the not-for-profit world and provide a neutral environment where we can work productively towards a common goal. Examples include:

  • NIH Research Portfolio — Supporting and raising funds for multiple projects initiated by the NIH, while also convening the right partners within and outside of the NIH.
  • Global Health — Coordinating and operating more than 50 collaborative projects in over 33 countries, including the Grand Challenges in Global Health (GCGH) supported by The Bill & Melinda Gates Foundation.
  • Biomarkers Consortium — Initiating and managing more than 16 projects funded with over $50 million in private dollars, designed to discover, develop and qualify biological markers to support new drug development, preventive medicine and medical diagnostics.

SYMPOSIA, EVENTS & EXHIBITS — We organize and facilitate more than 60 events each year, creating a forum for innovative thinkers in bioscience to share ideas and engage the public in disease and health awareness.

FELLOWSHIPS & AWARDS — We provide funding and training for early-career scientists, along with support and recognition for researchers whose findings have advanced biomedical science.

PROGRAM EXAMPLES
NIH Research: The Alzheimer’s Disease Neuroimaging Initiative created a new standard for cross-sector collaboration and data-sharing.
Global Health: Novel approach to control disease-spreading mosquitoes.
Biomarkers Consortium: The I-SPY Breast Cancer Trial is accelerating the development of targeted therapies.
Exhibit: The Smithsonian exhibition, Genome: Unlocking Life’s Code at the Natural Museum of History, opened in June 2013 to celebrate the anniversary of the sequencing of the human genome.
Award: The annual Lurie Prize in the Biomedical Sciences recognizes outstanding achievement by a promising scientist age 52 or younger.